☰

Najla Altwaijry - Publications

Affiliations: 
2018 University of Strathclyde, Glasgow, Scotland, United Kingdom 
Tree Info Similar researchers PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Thapa R, Gupta G, Bhat AA, Almalki WH, Alzarea SI, Kazmi I, Saleem S, Khan R, Altwaijry N, Dureja H, Singh SK, Dua K. A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies. International Journal of Biological Macromolecules. 253: 127375. PMID 37839597 DOI: 10.1016/j.ijbiomac.2023.127375  0.312
2021 Alsfouk AA, Alshibl HM, Altwaijry NA, Alsfouk BA, Al-Abdullah ES. Synthesis and biological evaluation of seliciclib derivatives as potent and selective CDK9 inhibitors for prostate cancer therapy Monatshefte FüR Chemie - Chemical Monthly. 152: 109-120. DOI: 10.1007/s00706-020-02727-x  0.327
2020 Sabour R, Harras MF, Mohamed Al Kamaly O, Altwaijry N. Discovery of Novel 3-Cyanopyridines as Survivin Modulators and Apoptosis Inducers. Molecules (Basel, Switzerland). 25. PMID 33105831 DOI: 10.3390/molecules25214892  0.401
2018 Laskar P, Somani S, Altwaijry N, Mullin M, Bowering D, Warzecha M, Keating P, Tate RJ, Leung HY, Dufès C. Redox-sensitive, cholesterol-bearing PEGylated poly(propylene imine)-based dendrimersomes for drug and gene delivery to cancer cells. Nanoscale. PMID 30488937 DOI: 10.1039/c8nr08141g  0.732
2018 Altwaijry N, Somani S, Dufès C. Targeted nonviral gene therapy in prostate cancer. International Journal of Nanomedicine. 13: 5753-5767. PMID 30310278 DOI: 10.2147/IJN.S139080  0.774
2018 Somani S, Laskar P, Altwaijry N, Kewcharoenvong P, Irving C, Robb G, Pickard BS, Dufès C. PEGylation of polypropylenimine dendrimers: effects on cytotoxicity, DNA condensation, gene delivery and expression in cancer cells. Scientific Reports. 8: 9410. PMID 29925967 DOI: 10.1038/s41598-018-27400-6  0.329
2018 Altwaijry N, Somani S, Parkinson JA, Tate RJ, Keating P, Warzecha M, Mackenzie GR, Leung HY, Dufès C. Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12. Drug Delivery. 25: 679-689. PMID 29493296 DOI: 10.1080/10717544.2018.1440666  0.733
Show low-probability matches.